£76.38

Springer Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phosphorylation Calcium-Activated Neutral Protease ... in Clinical Biochemistry and Medicine, 5)

Price data last checked 39 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£76 today · previous high £76 · all-time low £76

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 52 days · 52 data points (no recent data)

Historical
Generating forecast…
£76.38 £75.49 £75.68 £75.88 £76.07 £76.27 £76.46 23 April 2026 05 May 2026 18 May 2026 31 May 2026 13 June 2026

Price Distribution

Price distribution over 52 days • 1 price levels

Days at Price
52 days 0 13 26 39 52 £76 Days at Price

Price Analysis

Most common price: £76 (52 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 52 days

Description

Cholesterol is essential for normal cellular function. It is found in all cells of the body and is a major constituent of cell membranes. In addition, certain specialized tissues use cholesterol as the basic substrate for the synthesis of more complicated sterols such as bile acids and the steroid hormones. Like most lipids cholesterol has a very low solubility in water. Therefore, in order for these molecules to be transported be tween different organs of the body a series of lipid carriers known as lipoproteins has evolved. Over the last several years epidemiological evidence has accumulated suggest ing a strong relationship between the risk of atherosclerosis and high plasma concen trations of one of these lipoproteins, low density lipoprotein (LDL) 1). Thus, in popula tions with high plasma concentrations of LDL-cholesterol a correspondingly high incidence of vascular disease is seen. Since it has been demonstrated that reducing the steady-state plasma LDL-cholesterol concentration produces a proportional decrease in the risk of developing atherosclerosis 2), a major effort is now underway to develop safe and effective lipid lowering agents. In the past, these efforts have been hampered by a lack of knowledge concerning the physiological regulation of the plasma LDL-cholesterol concentration. However, recently there have been several major advances in these areas and it is now possible to precisely determine those factors that have the greatest effect on either increasing or decreasing the plasma LDL-cholesterol concentration.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Cellular Lipid Binding Proteins: 38 (Developments in Molecular and Cellular Biochemistry, 38)
80% match

Cellular Lipid Binding Proteins: 38 (Developments in Molecular and Cellular Biochemistry, 38)

Springer

£121.48 01 Jun 2026
Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)
79% match

Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)

Springer

£149.54 01 Jun 2026
Biochemistry of Atherosclerosis: 1 (Advances in Biochemistry in Health and Disease, 1)
79% match

Biochemistry of Atherosclerosis: 1 (Advances in Biochemistry in Health and Disease, 1)

Springer

£55.02 12 Jun 2026
Disorders of Lipid Metabolism
78% match

Disorders of Lipid Metabolism

Springer

£73.85 18 May 2026
Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)
78% match

Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)

Springer

£179.99 05 Jun 2026
Tobacco Smoking and Atherosclerosis: Pathogenesis and Cellular Mechanisms: 273 (Advances in Experimental Medicine and Biology, 273)
78% match

Tobacco Smoking and Atherosclerosis: Pathogenesis and Cellular Mechanisms: 273 (Advances in Experimental Medicine and Biology, 273)

Springer

£76.38 25 May 2026
Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention
77% match

Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention

Springer

£77.05 12 Jun 2026
High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL
77% match

High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL

Springer

£143.57 03 Jun 2026
Cell Growth and Cholesterol Esters (Molecular Biology Intelligence Unit)
77% match

Cell Growth and Cholesterol Esters (Molecular Biology Intelligence Unit)

Springer

£38.08 12 Jun 2026
Cholesterol Homeostasis: Methods and Protocols: 1583 (Methods in Molecular Biology, 1583)
76% match

Cholesterol Homeostasis: Methods and Protocols: 1583 (Methods in Molecular Biology, 1583)

Humana

£69.34 25 May 2026
Manual on Membrane Lipids (Springer Lab Manuals)
76% match

Manual on Membrane Lipids (Springer Lab Manuals)

Springer

£73.10 05 Jun 2026
The Bile Acids Chemistry, Physiology, and Metabolism: Volume 1: Chemistry
76% match

The Bile Acids Chemistry, Physiology, and Metabolism: Volume 1: Chemistry

Springer

£74.74 29 May 2026
High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 2. Improvement and Enhancement of HDL and Clinical Applications
76% match

High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 2. Improvement and Enhancement of HDL and Clinical Applications

Springer

£92.18 05 Jun 2026
Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)
76% match

Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)

Springer

£109.57 01 Jun 2026
Phosphatidylcholine: Biochemical and Clinical Aspects of Essential Phospholipids
76% match

Phosphatidylcholine: Biochemical and Clinical Aspects of Essential Phospholipids

Springer

£108.83 20 May 2026
Analysis of Sterols
76% match

Analysis of Sterols

Springer

£143.98 02 Jun 2026
Atherosclerosis: Cellular and Molecular Interactions in the Artery Wall - Symposium Proceedings: 1st (Altschul Symposium S.)
75% match

Atherosclerosis: Cellular and Molecular Interactions in the Artery Wall - Symposium Proceedings: 1st (Altschul Symposium S.)

Springer

£79.08 30 May 2026
Bioactive Lipids in Health and Disease: 1127 (Advances in Experimental Medicine and Biology, 1127)
75% match

Bioactive Lipids in Health and Disease: 1127 (Advances in Experimental Medicine and Biology, 1127)

Springer

£108.92 11 May 2026
Testosterone: From Basic to Clinical Aspects
75% match

Testosterone: From Basic to Clinical Aspects

Springer

£66.52 08 Jun 2026
The Phospholipases: 5 (Handbook of Lipid Research, 5)
75% match

The Phospholipases: 5 (Handbook of Lipid Research, 5)

Springer

£78.01 13 Jun 2026
Lipid Metabolism in the Healthy and Disease Heart: 8 (Developments in Molecular and Cellular Biochemistry, 8)
75% match

Lipid Metabolism in the Healthy and Disease Heart: 8 (Developments in Molecular and Cellular Biochemistry, 8)

Springer

£113.93 30 May 2026
Lipid Nutrition Guidelines
75% match

Lipid Nutrition Guidelines

£44.02 01 Jul 2026
Atherogenesis and Aging
74% match

Atherogenesis and Aging

Springer

£77.87 26 May 2026
Lipid Metabolism in Mammals: 2 (Monographs in Lipid Research, 2)
74% match

Lipid Metabolism in Mammals: 2 (Monographs in Lipid Research, 2)

Springer

£76.13 31 May 2026